Interstitial continuous infusion therapy in a malignant glioma model in rats

Purpose Local direct delivery of chemotherapeutic agents for the treatment of brain tumors is an area of focus in the development of new therapeutic paradigms. These techniques need improvement, especially in terms of drug retention in brain tissue. Materials and methods In this study, we used a rat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Child's nervous system 2009-06, Vol.25 (6), p.655-662
Hauptverfasser: Tange, Yuichi, Kondo, Akihide, Egorin, Merrill J., Mania-Farnell, Barbara, Daneriallis, Georgy M., Nakazaki, Hiromichi, Sredni, Simone T., Rajaram, Veena, Goldman, Stewart, Soares, Marcelo B., Tomita, Tadanori
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 662
container_issue 6
container_start_page 655
container_title Child's nervous system
container_volume 25
creator Tange, Yuichi
Kondo, Akihide
Egorin, Merrill J.
Mania-Farnell, Barbara
Daneriallis, Georgy M.
Nakazaki, Hiromichi
Sredni, Simone T.
Rajaram, Veena
Goldman, Stewart
Soares, Marcelo B.
Tomita, Tadanori
description Purpose Local direct delivery of chemotherapeutic agents for the treatment of brain tumors is an area of focus in the development of new therapeutic paradigms. These techniques need improvement, especially in terms of drug retention in brain tissue. Materials and methods In this study, we used a rat glioma model to examine carboplatin distribution, as measured by platinum penetration, after delivery via interstitial continuous (i.c.) infusion. We also examined rat survival times in response to carboplatin and oxaliplatin. I.C. infusion, a modified version of convection-enhanced delivery (CED) for local drug delivery, uses low volume (1 μl per hour) continuous infusion directly into the tumor. Results I.C. infusion produced a nearly 360-fold higher concentration of platinum in tumor tissue and significantly prolonged rodent survival time compared to intraperitoneal (i.p.) infusion. Conclusions We showed i.c. infusion allows for circumvention of the blood–brain barrier, focused drug distribution, and sustained drug delivery. This method could be a promising strategy for treating brain tumors.
doi_str_mv 10.1007/s00381-008-0805-3
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_754890518</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>754890518</sourcerecordid><originalsourceid>FETCH-LOGICAL-c374t-57d7dd452978f484502681abd7138d1f685184b1174d3bbc29461498d344d6e03</originalsourceid><addsrcrecordid>eNp9kD9PwzAQxS0EoqXwAVhQNqbAObZjZ0SIP5UqscBsObFTXCV2sZ2h3x5XqcTGdNK7957ufgjdYnjAAPwxAhCBSwBRggBWkjO0xJSQEgiDc7SEitUlBwoLdBXjDgAzUTWXaIGbClec0yXarF0yISabrBqKzrtk3eSnWFjXT9F6V6RvE9T-kIVCFaMa7NYpl4rtYP2YBa_NcNwFleI1uujVEM3Naa7Q1-vL5_N7ufl4Wz8_bcqOcJpKxjXXmrKq4aKngjKoaoFVqzkmQuO-FgwL2mLMqSZt21UNrTFthCaU6toAWaH7uXcf_M9kYpKjjZ0ZBuVMvl1yRkUDuSQ78ezsgo8xmF7ugx1VOEgM8shQzgxlZiiPDCXJmbtT-9SORv8lTtCyoZoNMa_c1gS581Nw-eN_Wn8BlJF7Xw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>754890518</pqid></control><display><type>article</type><title>Interstitial continuous infusion therapy in a malignant glioma model in rats</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Tange, Yuichi ; Kondo, Akihide ; Egorin, Merrill J. ; Mania-Farnell, Barbara ; Daneriallis, Georgy M. ; Nakazaki, Hiromichi ; Sredni, Simone T. ; Rajaram, Veena ; Goldman, Stewart ; Soares, Marcelo B. ; Tomita, Tadanori</creator><creatorcontrib>Tange, Yuichi ; Kondo, Akihide ; Egorin, Merrill J. ; Mania-Farnell, Barbara ; Daneriallis, Georgy M. ; Nakazaki, Hiromichi ; Sredni, Simone T. ; Rajaram, Veena ; Goldman, Stewart ; Soares, Marcelo B. ; Tomita, Tadanori</creatorcontrib><description>Purpose Local direct delivery of chemotherapeutic agents for the treatment of brain tumors is an area of focus in the development of new therapeutic paradigms. These techniques need improvement, especially in terms of drug retention in brain tissue. Materials and methods In this study, we used a rat glioma model to examine carboplatin distribution, as measured by platinum penetration, after delivery via interstitial continuous (i.c.) infusion. We also examined rat survival times in response to carboplatin and oxaliplatin. I.C. infusion, a modified version of convection-enhanced delivery (CED) for local drug delivery, uses low volume (1 μl per hour) continuous infusion directly into the tumor. Results I.C. infusion produced a nearly 360-fold higher concentration of platinum in tumor tissue and significantly prolonged rodent survival time compared to intraperitoneal (i.p.) infusion. Conclusions We showed i.c. infusion allows for circumvention of the blood–brain barrier, focused drug distribution, and sustained drug delivery. This method could be a promising strategy for treating brain tumors.</description><identifier>ISSN: 0256-7040</identifier><identifier>EISSN: 1433-0350</identifier><identifier>DOI: 10.1007/s00381-008-0805-3</identifier><identifier>PMID: 19212774</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer-Verlag</publisher><subject>Animals ; Antineoplastic Agents - administration &amp; dosage ; Antineoplastic Agents - pharmacokinetics ; Blood-Brain Barrier - drug effects ; Brain - drug effects ; Brain - metabolism ; Brain - pathology ; Brain Neoplasms - drug therapy ; Brain Neoplasms - mortality ; Brain Neoplasms - pathology ; Carboplatin - administration &amp; dosage ; Carboplatin - pharmacokinetics ; Catheterization ; Cell Line, Tumor ; Corpus Striatum - drug effects ; Disease Models, Animal ; Glioma - drug therapy ; Glioma - mortality ; Glioma - pathology ; Kaplan-Meier Estimate ; Male ; Medicine ; Medicine &amp; Public Health ; Neoplasm Transplantation ; Neurosciences ; Neurosurgery ; Organoplatinum Compounds - administration &amp; dosage ; Organoplatinum Compounds - pharmacokinetics ; Original Paper ; Platinum - metabolism ; Rats ; Rats, Inbred F344 ; Treatment Outcome</subject><ispartof>Child's nervous system, 2009-06, Vol.25 (6), p.655-662</ispartof><rights>Springer-Verlag 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c374t-57d7dd452978f484502681abd7138d1f685184b1174d3bbc29461498d344d6e03</citedby><cites>FETCH-LOGICAL-c374t-57d7dd452978f484502681abd7138d1f685184b1174d3bbc29461498d344d6e03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00381-008-0805-3$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00381-008-0805-3$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19212774$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tange, Yuichi</creatorcontrib><creatorcontrib>Kondo, Akihide</creatorcontrib><creatorcontrib>Egorin, Merrill J.</creatorcontrib><creatorcontrib>Mania-Farnell, Barbara</creatorcontrib><creatorcontrib>Daneriallis, Georgy M.</creatorcontrib><creatorcontrib>Nakazaki, Hiromichi</creatorcontrib><creatorcontrib>Sredni, Simone T.</creatorcontrib><creatorcontrib>Rajaram, Veena</creatorcontrib><creatorcontrib>Goldman, Stewart</creatorcontrib><creatorcontrib>Soares, Marcelo B.</creatorcontrib><creatorcontrib>Tomita, Tadanori</creatorcontrib><title>Interstitial continuous infusion therapy in a malignant glioma model in rats</title><title>Child's nervous system</title><addtitle>Childs Nerv Syst</addtitle><addtitle>Childs Nerv Syst</addtitle><description>Purpose Local direct delivery of chemotherapeutic agents for the treatment of brain tumors is an area of focus in the development of new therapeutic paradigms. These techniques need improvement, especially in terms of drug retention in brain tissue. Materials and methods In this study, we used a rat glioma model to examine carboplatin distribution, as measured by platinum penetration, after delivery via interstitial continuous (i.c.) infusion. We also examined rat survival times in response to carboplatin and oxaliplatin. I.C. infusion, a modified version of convection-enhanced delivery (CED) for local drug delivery, uses low volume (1 μl per hour) continuous infusion directly into the tumor. Results I.C. infusion produced a nearly 360-fold higher concentration of platinum in tumor tissue and significantly prolonged rodent survival time compared to intraperitoneal (i.p.) infusion. Conclusions We showed i.c. infusion allows for circumvention of the blood–brain barrier, focused drug distribution, and sustained drug delivery. This method could be a promising strategy for treating brain tumors.</description><subject>Animals</subject><subject>Antineoplastic Agents - administration &amp; dosage</subject><subject>Antineoplastic Agents - pharmacokinetics</subject><subject>Blood-Brain Barrier - drug effects</subject><subject>Brain - drug effects</subject><subject>Brain - metabolism</subject><subject>Brain - pathology</subject><subject>Brain Neoplasms - drug therapy</subject><subject>Brain Neoplasms - mortality</subject><subject>Brain Neoplasms - pathology</subject><subject>Carboplatin - administration &amp; dosage</subject><subject>Carboplatin - pharmacokinetics</subject><subject>Catheterization</subject><subject>Cell Line, Tumor</subject><subject>Corpus Striatum - drug effects</subject><subject>Disease Models, Animal</subject><subject>Glioma - drug therapy</subject><subject>Glioma - mortality</subject><subject>Glioma - pathology</subject><subject>Kaplan-Meier Estimate</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Neoplasm Transplantation</subject><subject>Neurosciences</subject><subject>Neurosurgery</subject><subject>Organoplatinum Compounds - administration &amp; dosage</subject><subject>Organoplatinum Compounds - pharmacokinetics</subject><subject>Original Paper</subject><subject>Platinum - metabolism</subject><subject>Rats</subject><subject>Rats, Inbred F344</subject><subject>Treatment Outcome</subject><issn>0256-7040</issn><issn>1433-0350</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kD9PwzAQxS0EoqXwAVhQNqbAObZjZ0SIP5UqscBsObFTXCV2sZ2h3x5XqcTGdNK7957ufgjdYnjAAPwxAhCBSwBRggBWkjO0xJSQEgiDc7SEitUlBwoLdBXjDgAzUTWXaIGbClec0yXarF0yISabrBqKzrtk3eSnWFjXT9F6V6RvE9T-kIVCFaMa7NYpl4rtYP2YBa_NcNwFleI1uujVEM3Naa7Q1-vL5_N7ufl4Wz8_bcqOcJpKxjXXmrKq4aKngjKoaoFVqzkmQuO-FgwL2mLMqSZt21UNrTFthCaU6toAWaH7uXcf_M9kYpKjjZ0ZBuVMvl1yRkUDuSQ78ezsgo8xmF7ugx1VOEgM8shQzgxlZiiPDCXJmbtT-9SORv8lTtCyoZoNMa_c1gS581Nw-eN_Wn8BlJF7Xw</recordid><startdate>20090601</startdate><enddate>20090601</enddate><creator>Tange, Yuichi</creator><creator>Kondo, Akihide</creator><creator>Egorin, Merrill J.</creator><creator>Mania-Farnell, Barbara</creator><creator>Daneriallis, Georgy M.</creator><creator>Nakazaki, Hiromichi</creator><creator>Sredni, Simone T.</creator><creator>Rajaram, Veena</creator><creator>Goldman, Stewart</creator><creator>Soares, Marcelo B.</creator><creator>Tomita, Tadanori</creator><general>Springer-Verlag</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>20090601</creationdate><title>Interstitial continuous infusion therapy in a malignant glioma model in rats</title><author>Tange, Yuichi ; Kondo, Akihide ; Egorin, Merrill J. ; Mania-Farnell, Barbara ; Daneriallis, Georgy M. ; Nakazaki, Hiromichi ; Sredni, Simone T. ; Rajaram, Veena ; Goldman, Stewart ; Soares, Marcelo B. ; Tomita, Tadanori</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c374t-57d7dd452978f484502681abd7138d1f685184b1174d3bbc29461498d344d6e03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Antineoplastic Agents - administration &amp; dosage</topic><topic>Antineoplastic Agents - pharmacokinetics</topic><topic>Blood-Brain Barrier - drug effects</topic><topic>Brain - drug effects</topic><topic>Brain - metabolism</topic><topic>Brain - pathology</topic><topic>Brain Neoplasms - drug therapy</topic><topic>Brain Neoplasms - mortality</topic><topic>Brain Neoplasms - pathology</topic><topic>Carboplatin - administration &amp; dosage</topic><topic>Carboplatin - pharmacokinetics</topic><topic>Catheterization</topic><topic>Cell Line, Tumor</topic><topic>Corpus Striatum - drug effects</topic><topic>Disease Models, Animal</topic><topic>Glioma - drug therapy</topic><topic>Glioma - mortality</topic><topic>Glioma - pathology</topic><topic>Kaplan-Meier Estimate</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Neoplasm Transplantation</topic><topic>Neurosciences</topic><topic>Neurosurgery</topic><topic>Organoplatinum Compounds - administration &amp; dosage</topic><topic>Organoplatinum Compounds - pharmacokinetics</topic><topic>Original Paper</topic><topic>Platinum - metabolism</topic><topic>Rats</topic><topic>Rats, Inbred F344</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tange, Yuichi</creatorcontrib><creatorcontrib>Kondo, Akihide</creatorcontrib><creatorcontrib>Egorin, Merrill J.</creatorcontrib><creatorcontrib>Mania-Farnell, Barbara</creatorcontrib><creatorcontrib>Daneriallis, Georgy M.</creatorcontrib><creatorcontrib>Nakazaki, Hiromichi</creatorcontrib><creatorcontrib>Sredni, Simone T.</creatorcontrib><creatorcontrib>Rajaram, Veena</creatorcontrib><creatorcontrib>Goldman, Stewart</creatorcontrib><creatorcontrib>Soares, Marcelo B.</creatorcontrib><creatorcontrib>Tomita, Tadanori</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Child's nervous system</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tange, Yuichi</au><au>Kondo, Akihide</au><au>Egorin, Merrill J.</au><au>Mania-Farnell, Barbara</au><au>Daneriallis, Georgy M.</au><au>Nakazaki, Hiromichi</au><au>Sredni, Simone T.</au><au>Rajaram, Veena</au><au>Goldman, Stewart</au><au>Soares, Marcelo B.</au><au>Tomita, Tadanori</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interstitial continuous infusion therapy in a malignant glioma model in rats</atitle><jtitle>Child's nervous system</jtitle><stitle>Childs Nerv Syst</stitle><addtitle>Childs Nerv Syst</addtitle><date>2009-06-01</date><risdate>2009</risdate><volume>25</volume><issue>6</issue><spage>655</spage><epage>662</epage><pages>655-662</pages><issn>0256-7040</issn><eissn>1433-0350</eissn><abstract>Purpose Local direct delivery of chemotherapeutic agents for the treatment of brain tumors is an area of focus in the development of new therapeutic paradigms. These techniques need improvement, especially in terms of drug retention in brain tissue. Materials and methods In this study, we used a rat glioma model to examine carboplatin distribution, as measured by platinum penetration, after delivery via interstitial continuous (i.c.) infusion. We also examined rat survival times in response to carboplatin and oxaliplatin. I.C. infusion, a modified version of convection-enhanced delivery (CED) for local drug delivery, uses low volume (1 μl per hour) continuous infusion directly into the tumor. Results I.C. infusion produced a nearly 360-fold higher concentration of platinum in tumor tissue and significantly prolonged rodent survival time compared to intraperitoneal (i.p.) infusion. Conclusions We showed i.c. infusion allows for circumvention of the blood–brain barrier, focused drug distribution, and sustained drug delivery. This method could be a promising strategy for treating brain tumors.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer-Verlag</pub><pmid>19212774</pmid><doi>10.1007/s00381-008-0805-3</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0256-7040
ispartof Child's nervous system, 2009-06, Vol.25 (6), p.655-662
issn 0256-7040
1433-0350
language eng
recordid cdi_proquest_miscellaneous_754890518
source MEDLINE; SpringerLink Journals
subjects Animals
Antineoplastic Agents - administration & dosage
Antineoplastic Agents - pharmacokinetics
Blood-Brain Barrier - drug effects
Brain - drug effects
Brain - metabolism
Brain - pathology
Brain Neoplasms - drug therapy
Brain Neoplasms - mortality
Brain Neoplasms - pathology
Carboplatin - administration & dosage
Carboplatin - pharmacokinetics
Catheterization
Cell Line, Tumor
Corpus Striatum - drug effects
Disease Models, Animal
Glioma - drug therapy
Glioma - mortality
Glioma - pathology
Kaplan-Meier Estimate
Male
Medicine
Medicine & Public Health
Neoplasm Transplantation
Neurosciences
Neurosurgery
Organoplatinum Compounds - administration & dosage
Organoplatinum Compounds - pharmacokinetics
Original Paper
Platinum - metabolism
Rats
Rats, Inbred F344
Treatment Outcome
title Interstitial continuous infusion therapy in a malignant glioma model in rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T02%3A01%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interstitial%20continuous%20infusion%20therapy%20in%20a%20malignant%20glioma%20model%20in%20rats&rft.jtitle=Child's%20nervous%20system&rft.au=Tange,%20Yuichi&rft.date=2009-06-01&rft.volume=25&rft.issue=6&rft.spage=655&rft.epage=662&rft.pages=655-662&rft.issn=0256-7040&rft.eissn=1433-0350&rft_id=info:doi/10.1007/s00381-008-0805-3&rft_dat=%3Cproquest_cross%3E754890518%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=754890518&rft_id=info:pmid/19212774&rfr_iscdi=true